The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
Condition(s):Heart TransplantationLast Updated:November 16, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Heart TransplantationLast Updated:November 16, 2022Enrolling by invitation
Condition(s):Acute Lymphoblastic Leukemia; Acute Lymphoblastic LymphomaLast Updated:May 25, 2023Active, not recruiting
Condition(s):Leukemia, Promyelocytic, AcuteLast Updated:January 14, 2008Completed
Condition(s):Adult-Onset Still’s DiseaseLast Updated:March 6, 2017Completed
Condition(s):Graft-versus-Host DiseaseLast Updated:December 11, 2013Terminated
Condition(s):Rheumatoid ArthritisLast Updated:August 10, 2017Completed
Condition(s):End Stage Renal Disease; Renal TransplantLast Updated:June 11, 2013Unknown status
Condition(s):Knee OsteoarthrosisLast Updated:May 3, 2023Recruiting
Condition(s):Castration-Resistant Prostatic NeoplasmsLast Updated:February 25, 2022Completed
Condition(s):Graft vs Host Disease; Kidney TransplantationLast Updated:April 28, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.